Trial Profile
Public health targeting of PrEP at HIV positives' bridging networks
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 15 Oct 2019
Price :
$35
*
At a glance
- Drugs Emtricitabine/tenofovir disoproxil fumarate (Primary)
- Indications HIV infections
- Focus Pharmacokinetics; Therapeutic Use
- 13 Oct 2019 Status changed from recruiting to completed.
- 15 Jun 2017 New trial record